ABIOMED (ABMD) has 2,083,291 shares of shorts outstanding as on August 15, 2016, with 5 days left to cover or roll them over. On Jul 29, 2016, the open interest of short positions was 2,793,595 shares. The stock has a decent trading volume of 439,438 shares daily. The marginal decrease in the short positions is by -25.4%, which amounts to -710,304 shares. Short positions are 5.2% of the available float. The short interest information was released on Wednesday Aug 24th after the market close.
ABIOMED (NASDAQ:ABMD): The stock opened at $121.49 on Wednesday but the bulls could not build on the opening and the stock topped out at $121.93 for the day. The stock traded down to $117.04 during the day, due to lack of any buying support eventually closed down at $117.40 with a loss of -3.03% for the day. The stock had closed at $121.07 on the previous day. The total traded volume was 346,596 shares.
In a related news, The Securities and Exchange Commission has divulged that Puhy Dorothy E, director of Abiomed Inc, had unloaded 5,160 shares at an average price of $123.94 in a transaction dated on August 15, 2016. The total value of the transaction was worth $639,530.
Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Companys products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.